Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1904286 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.82Day −3.05%Mkt cap $34M1Y −51.1%Off 52W high −66.7%Vol (1Y) 73.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 745 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.6% of sh out |
| Days to cover5.5d |
| 13F net flow (QoQ)+0.09% |
| Top-10 13F concentration90.0% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$9.8M |
| ROE−165.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−45.9% |
| 1Y−51.1% |
| Since incept. (ann.)−52.2% |
Total return through 2026-07-30 · series begins 2023-08-03. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)73.7% |
| Ann. volatility (3Y)387.0% |
| Sharpe (1Y)−0.64 |
| Sharpe (3Y)0.38 |
| Max drawdown (1Y)−54.6% |
| Max drawdown (3Y)−92.7% |
| Beta (3Y vs SPY)1.54 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 693,912 | $742,486 | 1.65% | new |
| Cross Staff Investments Inc | 359,401 | $384,559 | 0.86% | +0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 290,890 | $311,251 | 0.69% | +6.6% |
| VANGUARD FIDUCIARY TRUST CO | 169,483 | $181,347 | 0.40% | new |
| BlackRock, Inc. | 112,346 | $120,210 | 0.27% | +2.3% |
| Suncoast Equity Management | 90,645 | $96,990 | 0.22% | −12.2% |
| NORTHERN TRUST CORP | 67,698 | $72,437 | 0.16% | +0.0% |
| FIRST AMERICAN BANK | 60,000 | $64,200 | 0.14% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.03 | — | — | — |
| 2025-09-30 | 2025-11-13 | −$1.18 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$0.09 | — | — | — |
| 2025-03-31 | 2025-05-14 | −$0.11 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
